279 related articles for article (PubMed ID: 22861358)
1. Developments in rabies vaccines.
Hicks DJ; Fooks AR; Johnson N
Clin Exp Immunol; 2012 Sep; 169(3):199-204. PubMed ID: 22861358
[TBL] [Abstract][Full Text] [Related]
2. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
WHO Rabies Modelling Consortium
Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
[TBL] [Abstract][Full Text] [Related]
3. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
4. Update on human rabies in a dog- and fox-rabies-free country.
Stahl JP; Gautret P; Ribadeau-Dumas F; Strady C; Le Moal G; Souala F; Maslin J; Fremont B; Bourhy H
Med Mal Infect; 2014 Jul; 44(7):292-301. PubMed ID: 25011930
[TBL] [Abstract][Full Text] [Related]
5. Response to a rabies epidemic, Bali, Indonesia, 2008-2011.
Putra AA; Hampson K; Girardi J; Hiby E; Knobel D; Mardiana IW; Townsend S; Scott-Orr H
Emerg Infect Dis; 2013 Apr; 19(4):648-51. PubMed ID: 23632033
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis against rabies in children exposed to bats.
Willoughby RE; Hammarin AL
Pediatr Infect Dis J; 2005 Dec; 24(12):1109-10. PubMed ID: 16371876
[TBL] [Abstract][Full Text] [Related]
8. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
[TBL] [Abstract][Full Text] [Related]
10. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Blaney JE; Wirblich C; Papaneri AB; Johnson RF; Myers CJ; Juelich TL; Holbrook MR; Freiberg AN; Bernbaum JG; Jahrling PB; Paragas J; Schnell MJ
J Virol; 2011 Oct; 85(20):10605-16. PubMed ID: 21849459
[TBL] [Abstract][Full Text] [Related]
11. Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.
Gnanadurai CW; Yang Y; Huang Y; Li Z; Leyson CM; Cooper TL; Platt SR; Harvey SB; Hooper DC; Faber M; Fu ZF
PLoS Negl Trop Dis; 2015; 9(8):e0004023. PubMed ID: 26292099
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of animal rabies, Greece, 2012.
Tasioudi KE; Iliadou P; Agianniotaki EI; Robardet E; Liandris E; Doudounakis S; Tzani M; Tsaroucha P; Picard-Meyer E; Cliquet F; Mangana-Vougiouka O
Emerg Infect Dis; 2014 Feb; 20(2):326-8. PubMed ID: 24447622
[No Abstract] [Full Text] [Related]
13. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
Plummer JR; McGettigan JP
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
15. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.
Chen C; Zhang C; Li R; Wang Z; Yuan Y; Li H; Fu Z; Zhou M; Zhao L
Viruses; 2019 Dec; 11(12):. PubMed ID: 31816996
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
Huang F; Ahmad W; Duan M; Liu Z; Guan Z; Zhang M; Qiao B; Li Y; Song Y; Song Y; Chen Y; Amjad Ali M
Acta Virol; 2015 Jun; 59(2):117-24. PubMed ID: 26104328
[TBL] [Abstract][Full Text] [Related]
17. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
[TBL] [Abstract][Full Text] [Related]
18. Cross-protection of mice against a global spectrum of rabies virus variants.
Lodmell DL; Smith JS; Esposito JJ; Ewalt LC
J Virol; 1995 Aug; 69(8):4957-62. PubMed ID: 7609065
[TBL] [Abstract][Full Text] [Related]
19. Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths.
Wallace RM; Cliquet F; Fehlner-Gardiner C; Fooks AR; Sabeta CT; Setién AA; Tu C; Vuta V; Yakobson B; Yang DK; Brückner G; Freuling CM; Knopf L; Metlin A; Pozzetti P; Suseno PP; Shadomy SV; Torres G; Vigilato MAN; Abela-Ridder B; Müller T
Emerg Infect Dis; 2020 Dec; 26(12):1-9. PubMed ID: 33219786
[TBL] [Abstract][Full Text] [Related]
20. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.
Wen Y; Wang H; Wu H; Yang F; Tripp RA; Hogan RJ; Fu ZF
J Virol; 2011 Feb; 85(4):1634-44. PubMed ID: 21106736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
